Company: CSTL
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001447362-25-000069
Chunk: 0

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Item 1
Chunk 0
---
Item 1. Financial Statements.

CASTLE BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

March 31, 2025December 31, 2024ASSETS(unaudited)Current Assets  Cash and cash equivalents$89,689 $119,709 Marketable investment securities185,462 173,421 Accounts receivable, net56,353 51,218 Inventory6,849 8,135 Prepaid expenses and other current assets11,035 7,671 Total current assets349,388 360,154 Long-term marketable investment securities5,570 — Long-term accounts receivable, net1,000 918 Property and equipment, net55,423 51,122 Operating lease assets11,164 11,584 Goodwill and other intangible assets, net77,904 106,229 Other assets – long-term1,266 1,228 Total assets$501,715 $531,235 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent LiabilitiesAccounts payable$8,502 $6,901 Accrued compensation17,857 32,555 Operating lease liabilities1,435 1,665 Current portion of long-term debt1,111 278 Other accrued and current liabilities8,369 7,993 Total current liabilities37,274 49,392 Long-term debt8,921 9,745 Noncurrent operating lease liabilities14,049 14,345 Noncurrent finance lease liabilities328 311 Deferred tax liability837 1,607 Total liabilities61,409 75,400 Commitments and Contingencies (Note 11)Stockholders’ EquityPreferred stock, $0.001 par value per share; 10,000,000 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding as of March 31, 2025 and December 31, 2024— — Common stock, $0.001 par value per share; 200,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 28,844,937 and 28,483,195 shares issued and outstanding as of March 31, 2025 and December 31,